You are here

Africa

Merck to donate Ebola vaccine candidate for research program in Uganda

Merck to donate Ebola vaccine candidate for research program in Uganda | Reuters

Oct 25 (Reuters) - Merck & Co (MRK.N) said on Tuesday it was planning to produce and donate investigational Sudan ebolavirus vaccine to a global non-profit organization's research program in Uganda, which is facing an outbreak of the disease.

The investigational vaccine that will be donated to IAVI is similar to Merck's Ervebo vaccine, which is approved against the Zaire ebolavirus strain.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

COVID disrupted measles vaccinations in Africa ; now cases are surging

COVID disrupted measles vaccinations in Africa and now cases are surging | Reuters

The COVID-19 pandemic interrupted measles vaccine campaigns globally in 2020 and 2021, leaving millions of children unprotected against one of the world's most contagious diseases, whose complications include blindness, pneumonia and death.

After what health experts call the biggest backslide in a generation, 26 large or disruptive measles outbreaks have sprung up worldwide, according to the World Health Organization. A devastating outbreak in Zimbabwe has killed more than 700 children this year, chiefly among religious sects that do not believe in vaccinations.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Ebola: Uganda applies lessons from first outbreak, but reports increase in the capital

Uganda applies well-honed lessons to new Ebola outbreak (nbcnews.com)

...the East African country — lauded for its coronavirus response, which was built around engaging the community and training health officials — is drawing lessons from the first Ebola outbreak in 2004.

ALSO SEE: Uganda reports worrisome increase in Ebola cases in capital

Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Africa
howdy folks